HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Salfeld Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

3/2010CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Salfeld Research Topics

Disease

1Rheumatoid Arthritis
03/2010

Drug/Important Bio-Agent (IBA)

1Adalimumab (Humira)FDA Link
03/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010
1Biomarkers (Surrogate Marker)IBA
03/2010

Therapy/Procedure

1Therapeutics
03/2010